Detrimental antidepressant drug-drug interactions: Are they clinically relevant?

被引:20
|
作者
Preskorn, Sheldon [1 ]
Werder, Steve [1 ]
机构
[1] Univ Kansas, Sch Med, Dept Psychiat, Wichita, KS 67214 USA
关键词
antidepressants; drug-drug interactions; cytochrome P450 enzymes; serious adverse effects; polypharmacy;
D O I
10.1038/sj.npp.1301070
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This paper takes the position that detrimental drug-drug interactions (DDIs) involving antidepressants are clinically relevant. In doing so, it begins with a definition of the terms: drug-drug interaction, detrimental, and clinical relevance, It then discusses the issues of proof and provides an overview of the clinically relevant DDIs involving antidepressants. It also gives examples involving drugs besides antidepressants based on the premise that the underlying principles are applicable regardless of the therapeutic classes of the drugs involved.
引用
收藏
页码:1605 / 1612
页数:8
相关论文
共 50 条
  • [1] Detrimental Antidepressant Drug–Drug Interactions: Are They Clinically Relevant?
    Sheldon Preskorn
    Steve Werder
    [J]. Neuropsychopharmacology, 2006, 31 : 1605 - 1612
  • [2] Drug-Drug Interactions: Theoretical or Clinically Relevant?
    Martha, Gabriella
    Doro, Peter
    Benko, Ria
    Higyisan, Ilona
    Matuz, Maria
    Soos, Gyongyver
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S42 - S42
  • [3] Clinically relevant drug-drug interactions in oncology
    McLeod, HL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (06) : 539 - 544
  • [4] Clinically Relevant Drug-Drug Interactions in Primary Care
    Carpenter, Mary
    Berry, Holly
    Pelletier, Allen L.
    [J]. AMERICAN FAMILY PHYSICIAN, 2019, 99 (09) : 558 - 564
  • [5] A reference set of clinically relevant adverse drug-drug interactions
    Elpida Kontsioti
    Simon Maskell
    Bhaskar Dutta
    Munir Pirmohamed
    [J]. Scientific Data, 9
  • [6] A reference set of clinically relevant adverse drug-drug interactions
    Kontsioti, Elpida
    Maskell, Simon
    Dutta, Bhaskar
    Pirmohamed, Munir
    [J]. SCIENTIFIC DATA, 2022, 9 (01)
  • [7] Clinically relevant drug-drug interactions between antiretrovirals and antifungals
    Vadlapatla, Ramya Krishna
    Patel, Mitesh
    Paturi, Durga K.
    Pal, Dhananjay
    Mitra, Ashim K.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (04) : 561 - 580
  • [8] Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
    Vazquez, Sara R.
    [J]. BLOOD, 2018, 132 (21) : 2230 - 2239
  • [9] DALCETRAPIB HAS NO CLINICALLY RELEVANT DRUG-DRUG INTERACTIONS WITH PRAVASTATIN OR ROSUVASTATIN
    Derks, M.
    Abt, M.
    Phelan, M.
    Turnbull, L.
    Meneses-Lorente, G.
    Bech, N.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Clinically relevant drug-drug interactions among elderly people with dementia
    Sonnerstam, Eva
    Sjolander, Maria
    Lovheim, Hugo
    Gustafsson, Maria
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (10) : 1351 - 1360